Istanbullu, H. Et Al. 2023. Design, synthesis, in vitro – In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibition. European Journal of Medicinal Chemistry , vol.247 .

Istanbullu, H., Bayraktar, G., Karakaya, G., Akbaba, H., Perk, N. E., Cavus, I., ... Podlipnik, C.(2023). Design, synthesis, in vitro – In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibition. European Journal of Medicinal Chemistry , vol.247.

Istanbullu, Huseyin Et Al. "Design, synthesis, in vitro – In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibition," European Journal of Medicinal Chemistry , vol.247, 2023

Istanbullu, Huseyin Et Al. "Design, synthesis, in vitro – In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibition." European Journal of Medicinal Chemistry , vol.247, 2023

Istanbullu, H. Et Al. (2023) . "Design, synthesis, in vitro – In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibition." European Journal of Medicinal Chemistry , vol.247.

@article{article, author={Huseyin Istanbullu Et Al. }, title={Design, synthesis, in vitro – In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibition}, journal={European Journal of Medicinal Chemistry}, year=2023}